Baxter has initiated a nationwide recall for one lot of its Anticoagulant Sodium Citrate Solution due to the potential presence of particulate matter identified as fiberglass.
The solution is intended for use with automated apheresis devices, not direct intravenous infusion. Administration of contaminated solution could lead to adverse health consequences, including local vein irritation, inflammatory reactions, and systemic embolization, potentially causing tissue or organ injury if in-line filtration is absent.
The affected product was distributed to a single customer in the United States between July 2, 2026, and July 11, 2026. As of August 25, 2026, Baxter has not received any reports of adverse events related to this issue.
Consumers are advised to immediately discontinue use and return all affected units following their facility's procedures. Baxter is contacting the customer with return instructions. For questions, Baxter Healthcare Center for Service can be reached at 888-229-0001. The FDA encourages reporting adverse events or side effects related to these products to its MedWatch Safety Information and Adverse Event Reporting Program, which can be accessed online or by calling 1-800-332-1088 for a reporting form.